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Abstract
In vitro quantitative biosynthetic studies were carried out on bone marrow cells obtained from
an eleventh case with gamma heavy chain disease. The findings indicate that neither cytoplasmic
nor extracellular degradation was responsible for the presence of the gamma heavy chain fragment
in serum. The absence of a covalent-bound light chain was also confirmed.
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Abstract: In vitro quantitative biosynthetic studies were carried
out on bone marrow cells obtained from an eleventh case with
gamma heavy chain disease. The findings indicate that neither cyto-
plasmic nor extracellular degradation was responsible for the presence
of the gamma heavy chain fragment in serum. The absence of a
covalent-bound light chain was also confirmed.
The first case report of gamma heavy chain disease showed that extra-
cellular catabolism appears not to be responsible for the existence of anoma-
lous protein in patient serum (1). Several biosynthetic studies of the protein
were carried out with peripheral blood lymphocytes and with bone marrow
cells which showed the probable source of the labelled protein (2-4).
In vitro quantitative labeling studies carried out with cells obtained from
a patient with gamma heavy chain disease indicated that neither of the in-
complete chains appeared to be products of a primary intra- or extracellular
degradation process (5). The present studies with an eleventh case of the
disease is consistent with these findings.
METHODS
For biosynthetic studies of the Fc fragment, bone marrow cells were aspi-
rated in heparinized syringes from the iliac crest of the patient. The aspirates
were transferred to 10 ml of Eagle's minimal essential medium (MEM) with
1/20 the normal concentration of valine, threonine, and leucine, and 100 units
of heparin (1/20 medium) (6,7). The marrow cells were washed twice with
1/20 medium and then suspended in distilled water for 60 seconds to lyse the
red cells. The cell suspensions were then brought to isotonicity with 2x MEM.
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225
1
Arima et al.: Further studies on an eleventh case of heavy (Hgamma1) chain
Produced by The Berkeley Electronic Press, 1975
226 T. ARIMA et ai.
Cells were washed twice with 1/20 medium and resuspended at a final concen-
tration of 5x 106 to 1x 107 cells/milliliter. These procedures were carried out at
4°C. 20 p Ci each of 14C.labeled valine, threonine, and leucine was then added
to the cell suspensions for continuous labeling experiments. After exposure
for 60 seconds to a gentle stream of air containing 5% CO2 , the incubation was
started in a shaking water both at 37°C. Equal aliquots were then removed at
a given time and placed in an ice bath to stop protein synthesis.
For the prepartion of labeled cytoplasmic material, cells after incubation
were washed twice with cold MEM, treated with distilled water to lyse red
cells, and washed twice with cold MEM. Finally cells were suspended in phos-
phate buffered saline and disrupted by repeating freezing and thawing, three
times. Nonidet P-40 was then added to the solution at a final concentration of
0.5%, and it was spun at 100,000 g for 20 minutes to remove nuclei and ribo.
somes (6). To quantitate each immunoglobulin and molecular subunits of IgG
produced, they were precipitated with specific antisera obtained commercially
(Behringwerke AG, Marburg, Lahn, Germany and Handai Biken, Suita, Osa-
ka, Japan). Antiserum (100 pI) was added to the cytoplasm or secreted material
in the presence of an appropriate volume of "carrier" normal human serum
(2- 20 pI). Preliminary precipitin curves were carried out to ensure that all
precipitations were performed in antibody excess. The precipitates were
washed five times with cold phosphate buffered saline, and subjected to count.
ing of radioactivities. Total macromolecules synthesized were determined by
precipitation with 5% trichloroacetic acid in the presence of 5pI of normal
human serum. Radioactivities in precipitates formed by both methods were
analysed after their dissolving in 1% sodium dodecyl sulfate (SDS) at 37°C for
60 minutes.
For the identification of biosynthetic products, the cytoplasm and secreted
material were subjected to polyacrylamide electrophoresis (8) directly or after
precipitation with specific anti.sera. The products of synthesis were identified
by comparing their mobility to known marker proteins synthesized by bone
marrow cells of human IgG myelomas. The washed precipitates were dissolved
in 2% SDS with 0.03M iodoacetamide and 0.01 M sodium phosphate buffer, pH
6.7, and placed in a boiling water bath for 2 minutes (8). The SDS-dissociated
samples were subjected to electrophoresis on 12 cm, 9% acrylamide gels con·
taining 0.1 % SDS according to MAIZEL'S SDS.phos gel electrophoresis (8). In
this gel system, IgG, Fc fragment, and light chain were separated appropriate-
ly. For fractionation of gels, a Maizels gel grinder (Savant Instruments, Inc.,
Hicksville, N. Y.) and a gel slicer (Osaka Shoko, Inc., Toyonaka, Osaka) were
employed. The ground gel fractions were counted directly in a 10 ml of Bray's
scintillation cocktail. The sliced gels were suspended in 0.7 ml of 90% NCS
tissue solubilizeI' (AmershamjSearle Corp., Arlington Heights, Illinois), heated
at 50°C for 2 hours, and counted in the same cocktail. Counting of radio-
activity was performed in an Aloka LSC-502 or an Aloka LSC.60lB liquid
Scintillation counter.
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RESULTS
Seventy-two per cent of radioactivity incorporated in cytoplasmic mate-
rials was solubilized by freezing-thawing-Nonidet P-40 treatment and centri-
fugation at 60,000g. After four hours incubation, 43,000 cpm and 94,000
cpm of radioactivity were incorporated in secreted materials and in cyto-
plasmic materials, respectively. As shown in Table I, the radioactivity in
TABLE 1 !N'CORPORATION OF C14-LABELED AMINO ACIDS BY BONE MARROW
CELLS OF A HEAVY (H'Y 1 ) CHAIN DISEASE.
Protein fraction
precipitated by
specific anti serum
IgG
IgA
IgM
K
L
Fab
Fc
Alb
Radioactivi ty
in secreted
materials
39,8oocpm
1,700
3,100
1,900
2,100
1,300
41,000
2, 700
Radioactivity
in cytoplasmic
materials
4l,100cpm
1,100
2,900
1,400
1,800
1,300
38,200
1,200
5% TCA 43,000 94,000
To quantitate each immunoglobulins and molecular subunits of IgG produced, they
were precipitated by specific anti sera. Total biosynthetic product was precipitated by 5%
trichloroacetic acid (TCA). Note C14-r adioactivity was incorporated only in Fc and !gG
fractions, but not in Fab fraction suggesting synthesis of only Fc fragment. For a control,
the radioactivity precipitated by anti-albumin serum is also presented.
both secreted materials and cytoplamic materials was precipitated by anti-IgG
or anti Fe-serum, but not with anti-IgA, anti-IgM, anti-K, anti-L, anti-Fab
or anti-albumin. Ninety-five and three-tenths per cent and 43.7% of radio-
activity in secreted materials and in cytoplasmic materials were precipitated
by anti-Fc and anti-IgG, respectively. These results suggested that most
secreted materials and half of cytoplasmic materials synthesized in four
hour incubations were Fc fragment. Neither light chains nor Fd portion of
IgG molecule seemed to be present in either preparation. This conclusion
was confirmed by time course studies of bone marrow incubation (Fig. I).
Radioactivity in secreted materials was accummulated after a 60 minutes lag
and most radioactivity was precipitated with anti-IgG and anti-Fc sera but
not with anti-Fab serum. The radioactive cytoplasmic materials increased
in proportion to incubation time, and the concentration of radioactive mate-
rials precipitated by anti-IgG or anti-Fc was maintained in the same range
after five hours of incubation. No material precipitated with anti-Fab could
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Fig. 1. Time course studies on biosynthesis of M-component by bone marrow
cells.
A. Radioactivities in secreted material. B. Radioactivities in cytoplasmic
material. Immunoglobulins and molecular subunits of IgG were precipitated by
specific anti-sera. TCA, precipitated by 5% TCA; Fe, precipitated by anti-Fe;
IgG, precipitated by anti-IgG; Fab, precipitated by anti-Fab. Anti-K, and anti-L
gave the same results as anti-Fab. Note radioactivities were precipitated only by
anti-Fe or by anti-IgG in both preparations.
be found in the cytoplasm.
Secreted materials and cytoplasmic materials were electrophoresed in
acrylamide gels before and after the precipitation with anti-Fc and anti-IgG.
The patterns of fractionation are shown in Figs. 2 and 3. Two main peaks
appeared in both secreted and cytoplasmic materials, and only one peak
corresponding to Fe-fragment was found after immunological precipitation.
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Fig. 2. Fractionation in SDS-phos gel electrophoresis of 14Q-Iabeled secreted
material of bone marrow cells.
The supernatant of culture medium was electrophoresed. A. Without immu-
nologic precipitation, B. After precipitation with anti-Fc or anti-IgG serum.
Each sample was run with 3H-Iabeled IgG and light chain (Ll synthesized by bone
marrow cells of K type human IgG myeloma patient. The anode is at the right
and migration is toward the right. The migration of these markers is indicated on
the abcissa.
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DISCUSSION
Radioimmunoelectrophoretic and immunofluorescent studies on bone
marrow cells and lymph node cells suggested that cells synthesizing the ab-
normal protein were present in these preparations, and these cells did not
seem to produce an immunoglobulin light chains (2-4).
Bone marrow cells from our case (Yok) were incubated with radioactive
amino acids in a short-term tissue culture. Samples of soluble cytoplasmic
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Fig. 3. Fractionation on SDS-phos gel electrophoresis of 14C-Iabeled cytoplas-
mic material of bone marrow cell.
The cytoplasmic material was electrophoresed. A. Without immunologic pre-
cipitation, B. After precipitation with anti Fc or anti-IgG serum. They were
electrophoresed with labeled human immunoglobulin components as markers. The
migration of these markers is indicated on the abscissa. .
extracts and secreted materials were examined by immunologic precipitation
with specific anti-sera, and acrylamide gel electrophoresis in the presence of
sodium dodecyl sulfate. These methods are thought to be more sensitive
and quantitative than radioimmunoe1ectrophoresis and immunofluorescence
(9). Time course studies on the marrow cells were also performed. By these
experiments, it was found that bone marrow cells do not synthesize neither
whole IgG molecules nor the whole heavy gamma chain. Light chains could
not be found in both preparations while cells produced only the anomalous
protein related to Fc portion of IgG.
In the course of our studies, immunofluorescent and in vitro labeling
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studies on cells obtained from a patient with gamma heavy chain disease
(Va) have been reported from other laboratories (5). The report showed
no evidence of post-ribosomal intracellular degradation of normal size heavy
chain in the case, and intracellular polymerization of the aberrant peptides
appeared to take place in a similar manner to cells synthesizing intact heavy
chains. These results are compatible with our own observations.
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